Get the tools used by (smart)2 investors.

EPS Forecast (FINBOX) for Eli Lilly and Co

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

LLY: Eli Lilly and Co

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, H...

610.00 CHF
Price
CHF
Fair Value
Upside
605.00 - 840.00
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Eli Lilly and Co's EPS Forecast (FINBOX):

Dec 2026Dec 2028Dec 2030Dec 2032Dec 2034305070

Performance Summary
  • Eli Lilly's eps forecast for the next fiscal year is 19.02
  • Eli Lilly's eps forecast is expected to average 29.15 over the next 5 fiscal years.
  • Eli Lilly's is expected to deliver median eps forecast of 28.74 over the next 5 fiscal years.

How does Eli Lilly and's EPS Forecast (FINBOX) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Eli Lilly and Co because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: EPS Forecast

Hide this widget
eps_proj
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EPS Forecast (FINBOX) in the forecast category include:

View Full List

Search for metric or datapoint

EPS Forecast

Forecasted earnings per share (EPS).

Definition of EPS Forecast (FINBOX)

Hide this widget
Forecasted earnings per share (EPS).

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-11.28-4.282.7213.540200400

The chart above depicts the distribution of eps forecast (finbox) for companies operating in the Healthcare sector in the Developed economic region. Over 1,990 companies were considered in this analysis, and 1,919 had meaningful values. The average eps forecast (finbox) of companies in the sector is -0.13 with a standard deviation of 2.65.

Eli Lilly and Co's EPS Forecast (FINBOX) of 19.02 is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:

EPS Forecast (FINBOX) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,999
Included Constituents1,919
Min-12.18
Max13.12
Median-0.023
Mean-0.13
Standard Deviation2.65

You can find companies with similar eps forecast (finbox) using this stock screener.

All rights reserved. Terms Of Use